Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMI...
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study
About this item
Full title
Author / Creator
Publisher
San Francisco: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
San Francisco: Public Library of Science
Subjects
More information
Scope and Contents
Contents
To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in treatment-naïve patients with branch retinal vein occlusion (BRVO) enrolled in the LUMINOUS.sup.[TM] study. A 5-year, global, prospective, multicenter, observational, open-label study conducted in a clinical practice (real-world) setting at outpatient ophthalmolo...
Alternative Titles
Full title
Real-world outcomes with ranibizumab in branch retinal vein occlusion: The prospective, global, LUMINOUS study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2414724326
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2414724326
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0234739
